Researchers Identified New Neuronal Ferroptosis Regulator
A study published on September 22, 2026, details a signaling axis that protects neurons during chronic cerebral ischemia.
Updated on Sept. 22, 2026 in Stroke
Scientists have identified a signaling mechanism where the protein DOCK1-704aa inhibits ferroptosis, a type of cell death that worsens brain injury. This process involves the phosphorylation of the transcription factor TCF21 to maintain neuronal health.
Why it matters
Understanding this signaling pathway offers potential insights into how the brain manages damage during chronic cerebral ischemia. By preventing ferroptosis, this biological axis helps preserve Gpx4 and Fsp1 expression, which are critical for neuron survival.
The study characterized the DOCK1-704aa protein, which utilizes a specific phosphorylation site at serine 116 to regulate gene transcription. This mechanism was validated in mouse models of cerebral ischemia.
The players
IGF2BP3
This protein functions as a post-transcriptional regulator that influences the splicing of specific genes to modulate cell survival.
TCF21
This transcription factor acts as a regulator of gene expression and plays a central role in the ferroptosis defense mechanism identified in the study.
The details
The research found that IGF2BP3 promotes the reverse splicing of the Dock1 gene into circRNA Dock1, which subsequently encodes the DOCK1-704aa protein. This protein acts as a kinase that phosphorylates TCF21, relieving the repression of ferroptosis defense genes like Gpx4 and Fsp1.
Timeline
September 22, 2026: Article published.
The Big Picture
This discovery updates the established model of the ongoing investigation into ferroptosis in neurodegenerative diseases by identifying a novel regulatory axis for cell death prevention. It clarifies how specific protein-protein interactions function to mitigate neuronal damage.
While this discovery is currently limited to mouse models, it marks a shift toward identifying molecular targets for future ischemic stroke treatments. It provides a foundational understanding that may eventually influence the development of neuroprotective therapies.
The takeaway
This study highlights the critical role of DOCK1-704aa in suppressing neuronal cell death during ischemia. Researchers continue to explore how targeting specific phosphorylation sites could eventually lead to new clinical interventions for brain injury.
Further reading
Learn more about the latest research in the field of Stroke.
More information
Read the complete peer-reviewed research article regarding this signaling axis.
Source note: This article includes information reported by Nature.
